JPRN-UMIN000025725已完成2 期
Evaluation of safety and protective efficacy of fulminant hepatitis to abatacept treatment of patients with HBV-related severe hepatitis.-Pilot Study- - A pilot study of abatacept treatment for HBV fulminant hepatitis prevention.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) PT less than 10% 2) PT 61% or more, and either AST or ALT is on a downward trend 3) Hepatic encephalopathy 2 deg rees or more 4) Patients with autoimmune hepatitis 5) Patients with a history of hypersensitivity to orencia 6) Patients with severe infection 7) In addition, patients judg ed unsuitable for participation in this study by research doctor.
研究者
相似试验
已完成
3 期
Evaluation of Efficacy and Safety of Combination of Atorvastatin and Hydroxychloroquine with Atorvastatin alone in Patients with DyslipidemiaCTRI/2010/091/006138Ipca Laboratories Ltd Mumbai328
尚未招募
3 期
Comparative study of the efficacy and safety of FormoterolCTRI/2017/03/008277Rus Biopharm LLC136
招募中
3 期
A Phase III Study of FYU-981 in Hyperuricemic Pediatric Patients with or without Gout (Extension Study)JPRN-jRCT2041220061Fushimi Masahiko30
招募中
2 期
A observational study for safety and efficacy of Fulvestrant 500mg in postmenopausal patients with ER positive advanced or recurrent breast cancer after prior endocrine treatment. (SBCCSG-29)ocally advanced or metastatic breast cancerJPRN-UMIN000009110Saitama Breast Cancer Clinical Study Group(SBCCSG)100
招募中
Unknown
5-FU local injection for the treatment of advanced gastric cancerKCT0008395Kangbuk Samsung Medical Center35